DZ3343A1 - Derives de sulfonamide - Google Patents

Derives de sulfonamide

Info

Publication number
DZ3343A1
DZ3343A1 DZ013343A DZ013343A DZ3343A1 DZ 3343 A1 DZ3343 A1 DZ 3343A1 DZ 013343 A DZ013343 A DZ 013343A DZ 013343 A DZ013343 A DZ 013343A DZ 3343 A1 DZ3343 A1 DZ 3343A1
Authority
DZ
Algeria
Prior art keywords
sulfonamide derivatives
sulfonamide
derivatives
Prior art date
Application number
DZ013343A
Other languages
English (en)
Inventor
Macklin Brian Arnold
Thomas John Bleisch
George William Cuff
Dennis Michael Zimmerman
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ3343A1 publication Critical patent/DZ3343A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DZ013343A 2000-05-19 2001-05-04 Derives de sulfonamide DZ3343A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20600300P 2000-05-19 2000-05-19
PCT/US2001/011747 WO2001090057A1 (fr) 2000-05-19 2001-05-04 Derives de sulfonamide

Publications (1)

Publication Number Publication Date
DZ3343A1 true DZ3343A1 (fr) 2001-11-29

Family

ID=22764580

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013343A DZ3343A1 (fr) 2000-05-19 2001-05-04 Derives de sulfonamide

Country Status (24)

Country Link
US (1) US20030225163A1 (fr)
EP (1) EP1311474A1 (fr)
JP (1) JP2003534316A (fr)
KR (1) KR20030007644A (fr)
CN (1) CN1429205A (fr)
AR (1) AR035915A1 (fr)
AU (1) AU2001259053A1 (fr)
BR (1) BR0110874A (fr)
CA (1) CA2409830A1 (fr)
CZ (1) CZ20023797A3 (fr)
DZ (1) DZ3343A1 (fr)
EA (1) EA200201234A1 (fr)
EC (1) ECSP014078A (fr)
HR (1) HRP20020918A2 (fr)
HU (1) HUP0302255A3 (fr)
IL (1) IL152156A0 (fr)
MX (1) MXPA02010020A (fr)
NO (1) NO20025459L (fr)
PE (1) PE20020052A1 (fr)
PL (1) PL358180A1 (fr)
SK (1) SK16312002A3 (fr)
SV (1) SV2002000459A (fr)
WO (1) WO2001090057A1 (fr)
ZA (1) ZA200208749B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
US6984756B2 (en) 2000-05-19 2006-01-10 Eli Lilly And Company Process for preparing biphenyl compounds
ES2225558T3 (es) 2000-06-13 2005-03-16 Eli Lilly And Company Derivados de sulfonamida.
US20040235957A1 (en) * 2001-10-12 2004-11-25 David Bleakman Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (fr) * 2003-07-17 2005-02-17 Eli Lilly And Company Polytherapie pour le traitement de troubles cognitifs ou de psychoses
AU2007333247B2 (en) * 2006-12-11 2012-06-07 Eli Lilly And Company AMPA receptor potentiators
EP3311842A1 (fr) 2013-06-13 2018-04-25 VeroScience LLC Compositions et procédés de traitement des troubles métaboliques
EP3436021B1 (fr) 2016-03-29 2026-07-29 RespireRx Pharmaceuticals, Inc. Compositions comprenant des ampakines a faible impact pour traiter des troubles de déficit de l'attention

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525099B1 (en) * 1998-07-31 2003-02-25 Eli Lilly And Company N-substituted sulfonamide derivatives

Also Published As

Publication number Publication date
MXPA02010020A (es) 2003-02-12
WO2001090057A1 (fr) 2001-11-29
ECSP014078A (es) 2002-02-25
HRP20020918A2 (en) 2004-02-29
KR20030007644A (ko) 2003-01-23
JP2003534316A (ja) 2003-11-18
HUP0302255A3 (en) 2005-11-28
HUP0302255A2 (hu) 2003-11-28
AU2001259053A1 (en) 2001-12-03
IL152156A0 (en) 2003-05-29
PL358180A1 (en) 2004-08-09
US20030225163A1 (en) 2003-12-04
CA2409830A1 (fr) 2001-11-29
EP1311474A1 (fr) 2003-05-21
NO20025459D0 (no) 2002-11-14
AR035915A1 (es) 2004-07-28
BR0110874A (pt) 2003-02-11
CZ20023797A3 (cs) 2003-04-16
CN1429205A (zh) 2003-07-09
EA200201234A1 (ru) 2003-04-24
PE20020052A1 (es) 2002-02-02
ZA200208749B (en) 2004-01-30
NO20025459L (no) 2002-11-14
SK16312002A3 (sk) 2003-05-02
SV2002000459A (es) 2002-07-03

Similar Documents

Publication Publication Date Title
DZ3439A1 (fr) Derives de 2-aminocarbonyl-9h-purine
PT1175408E (pt) Derivados sulfonamida
PT1303521E (pt) Derivados de tetra-hidro-heterocicloazepinil-pirimidina
MXPA03000059A (es) Derivados de pirazol.
DK1280809T3 (da) Antitumorecteinascidinderivater
DE60140253D1 (de) Oreinheit
ATE298332T1 (de) Decahydro-isochinolinderivate
ATE459598T1 (de) Sulfonamidderivate
FR2810318B1 (fr) Derives de diamano-phenothiazine
ATE414056T1 (de) Substituierte c-cyclohexylmethylamin-derivative
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
PT1351959E (pt) Novos derivados de pleuromutilina
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
DZ3344A1 (fr) Derives de sulfonamide
PT1246791E (pt) Derivados de aminometilfenilciclo-hexanona
NO20025459D0 (no) Sulfonamidderivater
DE50112454D1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
DK1345892T3 (da) Acylaminoalkylsubstituerede benzensulfonamidderivater
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater